Table of Contents

company-logo

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.

Mirum Pharmaceuticals Dividend Announcement

• Mirum Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Mirum Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Mirum Pharmaceuticals Dividend History

Mirum Pharmaceuticals Dividend Yield

Mirum Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Mirum Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Mirum Pharmaceuticals Financial Ratios

P/E ratio-21.74
PEG ratio-0.22
P/B ratio9.12
ROE-41.22%
Payout ratio0.00%
Current ratio3.34
Quick ratio3.15
Cash Ratio1.93

Mirum Pharmaceuticals Dividend FAQ

Does Mirum Pharmaceuticals stock pay dividends?
Mirum Pharmaceuticals does not currently pay dividends to its shareholders.
Has Mirum Pharmaceuticals ever paid a dividend?
No, Mirum Pharmaceuticals has no a history of paying dividends to its shareholders. Mirum Pharmaceuticals is not known for its dividend payments.
Why doesn't Mirum Pharmaceuticals pay dividends?
There are several potential reasons why Mirum Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Mirum Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Mirum Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Mirum Pharmaceuticals a dividend aristocrat?
Mirum Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Mirum Pharmaceuticals a dividend king?
Mirum Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Mirum Pharmaceuticals a dividend stock?
No, Mirum Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Mirum Pharmaceuticals stocks?
To buy Mirum Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Mirum Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.